SCHEMBL2504972

SCHEMBL2504972

CCc1ccc(C2CCCC2)c(OC(=O)c2ccccc2)c1OC(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.40
LMNA P02545 4/20 0.40
CYP1A2 P05177 2/20 0.40
SCN1A P35498 2/20 0.40
SCN2A Q99250 2/20 0.40
SCN3A Q9NY46 2/20 0.40
CYP2D6 P10635 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 1/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
STAT3 P40763 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA5 P30532 1/20 0.38
CHRNA7 P36544 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2510592 0.99 PTGDR2 (0.42) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2508572 0.91 LMNA (0.38) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2502665 0.90 PTGDR2 (0.40) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2508814 0.89 CNR1 (0.39) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2503619 0.89 KMT2A (0.46) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2507228 0.88 CNR1 (0.41) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2508869 0.88 LMNA (0.42) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2509192 0.87 KMO (0.47) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2508681 0.87 KMO (0.47) PTGDR2LMNACYP1A2SCN1ASCN2A
SCHEMBL2508225 0.87 LMNA (0.44) PTGDR2LMNACYP1A2SCN1ASCN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104860826-A Production of substituted phenylene aromatic diesters DOW GLOBAL TECHNOLOGIES LLC 2015-08-26 CN disclosed
CN-102741215-B Production of substituted phenylene aromatic diesters DOW GLOBAL TECHNOLOGIES INC 2015-04-29 CN disclosed
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
CN-102741215-A Production of substituted phenylene aromatic diesters DOW GLOBAL TECHNOLOGIES INC 2012-10-17 CN disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT PTGDR2 1971/4885LMNA 4145/4885CYP1A2 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.